NCT06181175View on ClinicalTrials.gov

Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

October 30, 2024

Study Completion Date

April 30, 2025

Conditions
Benign Prostatic HyperplasiaUrinary ObstructionLower Urinary Tract Symptoms
Interventions
DRUG

PEAPROSTIL 600 + Tamsulosin 0.4 mg

PEAPROSTIL 600 mg one sachet oral daily+ Tamsulosin 0.4 mg one tablet oral daily

DRUG

Tamsulosin 0.4 mg

Tamsulosin 0.4 mg one tablet oral daily

DRUG

PEAPROSTIL 600 mg

PEAPROSTIL 600 mg one sachet oral daily

Trial Locations (1)

28100

RECRUITING

Michele Billia, Novara

All Listed Sponsors
lead

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER